Mexican pharmaceutical manufacturer across diabetes, cardiovascular, and specialty care
Laboratorios Silanes is a Mexico-based pharmaceutical manufacturer operating across eight therapeutic areas—diabetes, cardiovascular disease, pain management, gastrointestinal health, CNS, gynecology, antivenoms, and gender-specific wellness. The tech stack (Python, SQL, FastAPI, Docker, AWS/GCP/Azure, Power BI) reveals an organization modernizing data operations and analytics infrastructure. Active hiring spans sales, data, legal, and manufacturing, with velocity accelerating—a pattern consistent with portfolio expansion and commercial scaling in a highly regulated market.
Laboratorios Silanes manufactures and commercializes pharmaceutical treatments across eight therapeutic areas, serving patients across Mexico. Founded in 1943, the company operates with 1,001–5,000 employees from headquarters in Mexico City. The business spans primary care and specialty segments, with stated focus on diabetes, cardiovascular disease, pain management, gastrointestinal health, central nervous system disorders, gynecology, antivenoms, and gender-specific health products. Recent project activity centers on sales dashboard development and commercial strategy evaluation, while organizational challenges center on regulatory affairs, protecting intellectual property in the medical portfolio, portfolio acceleration, and manufacturing optimization.
Python, SQL, FastAPI, Docker, Git, Power BI, Excel, across AWS, GCP, and Azure cloud platforms.
Eight: diabetes, cardiovascular disease, pain management, gastrointestinal health, central nervous system disorders, gynecology, antivenoms, and gender-specific health products.
Other companies in the same industry, closest in size